申请人:Hammond Marlys
公开号:US20080194536A1
公开(公告)日:2008-08-14
The present invention relates to a compound represented by the following formula:
(I) or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof, or a combination thereof, wherein R
o
, R
1
, R
1′
, R
2
, R
2′
, R
3
and n are defined herein. The present invention further relates to a method of treating a patient from endometreosis or uterine fibroids.
本发明涉及下列式(I)所表示的化合物,或其药学上可接受的盐,或其药学上可接受的溶剂合物,或其组合物,其中Ro,R1,R1',R2,R2',R3和n在此定义。本发明还涉及治疗子宫内膜异位症或子宫肌瘤患者的方法。